IMDX — Insight Molecular Diagnostics Inc. · rev $271.0K

Insight Molecular Diagnostics Inc. (IMDX) is a diagnostics & research company listed on US.

Latest reported IMDX revenue for 2026-06-30 was $271.0K. Net income was -$15.6M. IMDX currently screens at market cap $0.

Use this IMDX page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the IMDX quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the IMDX SEC filings page. Lician reads the product cache first so this HTML stays unique to Insight Molecular Diagnostics Inc. even when a live quote feed is slow.

Insight Molecular Diagnostics Inc. latest statements (FY2025)

Latest cached year on this hub. Full IMDX income, balance, and cash tables.

  • Revenue$4.1M
  • Net Income-$50.2M
  • Total Assets$25.8M
  • Total Debt$0
  • Free Cash Flow-$25.4M